Employers only pay when predefined outcomes are achieved Guaranteed improvements in A1C, weight loss, and deprescription of GLP-1s and other medications ROI is validated using pharmacy and medical claims data Reported outcomes include a 2.2-point average A1C reduction for members with starting A1C greater than8.0 and a 14-pound average weight loss for members with a BMI greater than 30, based on internal data from Twin Healths commercial populations as of September 2024 Demonstrated reductions in diabetes-related pharmacy spend while maintaining clinical appropriateness Precision medication management Employers can start by using claims and clinical data to identify risk levels and guide GLP-1 eligibility
M., Czyzyk, A., Meczekalski, B., & Genazzani, A
It is also used in dermatology to lighten skin and fight the visible signs of aging
Sustained Weight Loss Over Time Now, its not just about that initial burst
It really takes the risk of dosing out of the hands of the patient, Sesame co-founder and president Michael Botta told USA TODAY
If you already take a GLP-1 medication and have Afib or are at increased risk for it, this research shows that you may be getting an added heart health benefit beyond weight loss or blood sugar control